Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-73131-y
Affiliations:
2
Authors:
16
Go to article
Institutions Authors Share
State Key Laboratory of Oncology in South China, SYSUCC, China
16.000000
16.000000
 1.00
Interested in Oncology and Carcinogenesis?